Codrituzumab-MMAE
Product Specifications
Target
Apoptosis related
Applications
Apoptosis
Additionnal Information
Codrituzumab-MMAE, is an antibody-drug conjugate composed of a anti-GPC3 monoclonal antibody and a cytotoxic tubulin polymerase inhibitor conjugated through MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) type linker.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
More Discoveries
Explore Other Products
Browse additional items from our catalog
OB165483-01 100 mg
Benzyl 4-O- (2,6-di-O-benzyl-b-D-galactopyranosyl) -2,3,6-tri-O-benzyl-D-glucopyranoside
Sign In for Pricing
View Details OB165483-02 250 mg
Benzyl 4-O- (2,6-di-O-benzyl-b-D-galactopyranosyl) -2,3,6-tri-O-benzyl-D-glucopyranoside
Sign In for Pricing
View Details 
OB165483-03 500 mg
Benzyl 4-O- (2,6-di-O-benzyl-b-D-galactopyranosyl) -2,3,6-tri-O-benzyl-D-glucopyranoside
Sign In for Pricing
View Details 
OB165483-04 1000 mg
Benzyl 4-O- (2,6-di-O-benzyl-b-D-galactopyranosyl) -2,3,6-tri-O-benzyl-D-glucopyranoside
Sign In for Pricing
View Details 
OB165483-05 2000 mg
Benzyl 4-O- (2,6-di-O-benzyl-b-D-galactopyranosyl) -2,3,6-tri-O-benzyl-D-glucopyranoside
Sign In for Pricing
View Details